In this review:
Histological regression and outcome in stage 1–2 cutaneous melanoma
Melanoma recurrence after adjuvant targeted therapy
Eccentric hyperpigmentation should raise suspicion of melanoma
Long-term safety of pembrolizumab, and relationship with clinical outcome
Risk factors and timing of developing subsequent SCC
Nivolumab + ipilimumab for treatment-naïve metastatic uveal melanoma
Dermoscopic inverse approach improves lentigo maligna diagnosis by human readers
Cutaneous toxicities with checkpoint inhibitors for melanoma
Discrepancies between biopsy and Mohs micrographic surgery in keratinocyte carcinoma
Please login below to download this issue (PDF)